Compare BALL & GMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BALL | GMED |
|---|---|---|
| Founded | 1880 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.8B | 11.3B |
| IPO Year | N/A | 2012 |
| Metric | BALL | GMED |
|---|---|---|
| Price | $51.08 | $86.11 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 14 |
| Target Price | $61.75 | ★ $93.09 |
| AVG Volume (30 Days) | ★ 2.8M | 1.6M |
| Earning Date | 02-03-2026 | 11-06-2025 |
| Dividend Yield | ★ 1.57% | N/A |
| EPS Growth | N/A | ★ 358.86 |
| EPS | 2.40 | ★ 3.08 |
| Revenue | ★ $12,694,000,000.00 | $2,769,804,000.00 |
| Revenue This Year | $11.82 | $16.66 |
| Revenue Next Year | $4.19 | $8.27 |
| P/E Ratio | ★ $21.24 | $28.15 |
| Revenue Growth | 7.41 | ★ 11.75 |
| 52 Week Low | $43.51 | $51.79 |
| 52 Week High | $60.29 | $94.93 |
| Indicator | BALL | GMED |
|---|---|---|
| Relative Strength Index (RSI) | 62.42 | 56.40 |
| Support Level | $46.65 | $87.72 |
| Resistance Level | $49.46 | $91.12 |
| Average True Range (ATR) | 1.00 | 2.03 |
| MACD | 0.25 | -1.24 |
| Stochastic Oscillator | 96.15 | 6.26 |
Ball is the world's largest metal can manufacturer with market share over 30% in its three main regions (North America, Europe, and South America). The company is focused on increasing capacity amid a wave of new developed-market demand, while also investing in faster-growing emerging-market economies. Ball spun-off its glass jar business in 1993 and is now owned by Newell. The company reports three segments—beverage packaging, North and Central America (48% of 2024 revenue), beverage packaging, EMEA (29%), beverage packaging, South America (17%)—and it generated $12 billion in revenue in 2024.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.